In one of the most substantial deals of the year so far, Abridge on Tuesday announced it raised a $300 million Series E ...

Nektar Therapeutics said its embattled immune drug rezpeg significantly improved skin clearance rates in patients with atopic ...

She wrote that she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering ...

Researchers have estimated Medicaid cuts could result in more than 16,600 preventable deaths a year. But they also say that’s ...

Novo Nordisk terminated its marketing relationship with Hims & Hers, accusing the telehealth company of deceptive marketing ...

New data indicate a targeted drug from Nuvalent could help patients with a rare lung cancer for whom other drugs stopped ...

The U.S. may be headed for a “choose your own adventure” approach to vaccine policy, in which skeptical parents follow the ...

We have had the ability to prevent nearly all cases of measles for more than 60 years. Yet the number of cases keeps growing.

Cheatham is the new head of health care and life sciences at Breyer Capital, the investment office of Jim Breyer, who is ...

Semler Scientific is now focused on bitcoin, after a series of escalating threats to its core artery-testing business.

Despite a significant increase in injections, today's vaccines expose children to a fraction of the immune-stimulating ...

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by ...